Published in J Exp Med on February 01, 1974
Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall. Infect Immun (1978) 2.57
Suppression of the immune response by microorganisms. Bacteriol Rev (1975) 2.53
Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med (1974) 2.45
Third component of complement (C3): structural properties in relation to functions. Proc Natl Acad Sci U S A (1975) 2.21
Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin. J Exp Med (1980) 1.96
Murine B-cell subpopulations responsive to T-dependent and T-independent antigens. J Exp Med (1976) 1.49
Prolonged C3 depletion by cobra venom factor in thymus-deprived mice and its implication for the role of C3 as an essential second signal for B-cell triggering. Immunology (1975) 1.44
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
Stimulation of murine B lymphocytes by isolated C3b. J Exp Med (1975) 1.25
The requirement for C3 receptors on the precursors of 19S and 7S antibody-forming cells. J Exp Med (1976) 1.22
Activation of the classical and alternate pathways of complement by Corynebacterium parvum. Clin Exp Immunol (1975) 1.18
Activation of the alternative pathway by gluten. A possible aetiological factor in dermatitis herpetiformis. Immunology (1977) 1.15
Immunogenicity of lipid-conjugated antigens. II. Anti-complementary activity and antigen trapping in the spleen. Immunology (1980) 1.04
C3-mediated cytoadherence. Formation of C3 receptor aggregates as prerequisite for cell attachment. J Exp Med (1975) 1.04
Binding of components of the properdin system to cultured human lymphoblastoid cells and B lymphocytes. J Exp Med (1976) 1.01
Immunogenicity of lipid-conjugated protein in the intestine. Immunology (1975) 1.00
Binding of fluid-phase complement components C3 and C3b to human lymphocytes. Biochem J (1981) 0.94
Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses. J Exp Med (1982) 0.90
Regulation of immunoglobulin secretion by factor H of human complement. Immunology (1985) 0.85
The role of complement in the induction and regulation of immune responses. Immunology (1984) 0.84
Enhancement of in vitro immunoglobulin synthesis of human lymphocytes by lysosomal enzymes from polymorphonuclear leucocytes. Clin Exp Immunol (1977) 0.81
Inhibition of human lymphocyte blastogenesis by C3: the role of serum in the tissue culture medium. Immunology (1982) 0.78
Stimulation of complement production in mice by N alpha-(N-acetylmuramyl-L-alanyl-D-isoglutamine)-N epsilon-stearoyl-L-lysine. Infect Immun (1983) 0.77
Tissue localization of complement component 3 receptor-bearing cells in lymphoid tissue after injection with complete Freund adjuvant. Infect Immun (1982) 0.75
Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement. Immunology (1983) 0.75
Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93
A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med (1970) 15.86
Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol (1969) 6.97
Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J Exp Med (1971) 5.43
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Thymus dependence of theta-bearing cells in the peripheral lymphoid tissues of mice. Immunology (1970) 3.84
Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28
Homozygous deficiency of C3 in a patient with repeated infections. Lancet (1972) 3.04
The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro. J Exp Med (1972) 2.95
Mechanism of binding of soluble immune complexes to lymphocytes. Cell Immunol (1973) 2.93
Role of complement in induction of the allergic response. Nat New Biol (1972) 2.90
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Hypothesis. Bound C3 as the second signal for B-cell activation. Cell Immunol (1973) 2.49
Tolerance, enhancement and the regulation of interactions between T cells, B cells and macrophages. Transplant Rev (1972) 2.44
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Lymphocyte activation. II. discriminating stimulation of lymphocyte subpopulations by phytomitogens and heterologous antilymphocyte sera. Clin Exp Immunol (1972) 2.37
Evidence for a small pool of immunocompetent cells in the mouse thymus. Its role in the humoral antibody response against sheep erythrocytes, bovine serum albumin, ovalbumin and the NIP determinant. Cell Immunol (1970) 2.00
Sites of synthesis of serum proteins. OI. Serum proteins produced by macrophages in vitro. J Immunol (1967) 1.96
Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement. Proc Natl Acad Sci U S A (1969) 1.92
Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry (1970) 1.81
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action. Eur J Immunol (1973) 1.80
Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80
Stimulation of humoral antibody formation by polyanions. 3. Restoration of the immune response to sheep red blood cells by polyanions in thymectomized and lethally irradiated mice protected with bone marrow cells. Eur J Immunol (1971) 1.66
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Specific activation of the bone marrow-derived lymphocyte by antigen presented in a non-multivalent form. J Exp Med (1973) 1.46
C3 split products inhibit the binding of antigen-antibody-complement complexes to B lymphocytes. J Immunol (1973) 1.28
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Selective stimulation of mouse lymphocyte populations by lectins. Int Arch Allergy Appl Immunol (1973) 0.98
A MICRO-SLIDE METHOD PERMITTING AUTORADIOGRAPHY OF HAEMOLYSIN-PRODUCING CELLS. Nature (1964) 0.86
A three-cell mosaic culture: in vitro immune response by a combination of pure B- and T-cells with peritoneal macrophages. Cell Immunol (1972) 0.84
Effect of cyclic AMP on release of lysosomal enzymes from phagocytes. Nat New Biol (1971) 4.09
[A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives]. Chem Ber (1970) 3.77
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol (1991) 3.60
Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29
The ninth component of human complement: isolation, description and mode of action. Immunology (1969) 2.96
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol (1991) 2.72
An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues. J Immunol (1987) 2.54
Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics (1998) 2.50
Hypothesis. Bound C3 as the second signal for B-cell activation. Cell Immunol (1973) 2.49
NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci U S A (1985) 2.49
Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. Proc Natl Acad Sci U S A (1970) 2.29
Molecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli. J Bacteriol (1986) 2.23
Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol (1985) 2.18
Complement: substitution of the terminal component in immune hemolysis by 1,10-phenanthroline. Science (1967) 2.11
Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis (1995) 1.97
CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob Agents Chemother (1998) 1.91
Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B. Infect Immun (1991) 1.87
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation. Immunology (1977) 1.82
Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5. Immunochemistry (1970) 1.81
Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology (1994) 1.81
Bone marrow origin of complement-receptor lymphocytes. Eur J Immunol (1971) 1.80
In vitro synthesis of factor B of the alternative pathway of complement activation by mouse peritoneal macrophages. Eur J Immunol (1976) 1.78
Retrotransposon R1Bm endonuclease cleaves the target sequence. Proc Natl Acad Sci U S A (1998) 1.75
Cystatin C serum concentrations underestimate glomerular filtration rate in renal transplant recipients. Clin Chem (1999) 1.73
Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73
Biosynthesis of enterobacterial common antigen. J Bacteriol (1985) 1.72
Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells. Infect Immun (1986) 1.70
Interaction of the first (C1), the second (C2) and the fourth (C4) component of complement with different preparations of bacterial lipopolysaccharides and with lipid A. J Immunol (1974) 1.69
Ability of the T cell-replacing polyanion dextran sulfate to trigger the alternate pathway of complement activation. Eur J Immunol (1973) 1.68
The immunological responsiveness of germ-free mice thymectomized at birth. I. Antibody production and skin homograft rejection. Clin Exp Immunol (1967) 1.66
Release of leukotriene C4 from human polymorphonuclear leucocytes as determined by radioimmunoassay. FEBS Lett (1982) 1.66
Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res (2001) 1.64
Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes. Curr Top Microbiol Immunol (1985) 1.63
Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J Clin Microbiol (2009) 1.62
Bacterial adherence and hemolysin production from Escherichia coli induces histamine and leukotriene release from various cells. Infect Immun (1985) 1.61
Expression of the Escherichia coli K5 capsular antigen: immunoelectron microscopic and biochemical studies with recombinant E. coli. J Bacteriol (1990) 1.61
Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry (2006) 1.59
Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58
Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med (1998) 1.57
Interaction of C3b, B, and D in the alternative pathway of complement activation. J Immunol (1975) 1.55
Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest (1991) 1.55
Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol (1991) 1.50
Characterization and function of T cell Fc gamma receptor. Immunol Rev (1981) 1.50
Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients. Am J Transplant (2013) 1.49
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. J Antimicrob Chemother (1998) 1.48
Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom. Immunology (1972) 1.47
Interactions between Mycoplasma pneumoniae and guinea pig complement. Infect Immun (1975) 1.47
Genetic classification and distinguishing of Staphylococcus species based on different partial gap, 16S rRNA, hsp60, rpoB, sodA, and tuf gene sequences. J Clin Microbiol (2008) 1.47
The role of lysosomes in immune responses. Adv Immunol (1970) 1.47
Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res (1990) 1.46
Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates. J Med Microbiol (1998) 1.45
Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. Microb Pathog (1987) 1.45
Cetirizine counter-regulates interleukin-8 release from human epithelial cells (A549) Clin Exp Allergy (1999) 1.45
DNP-antigens activate the alternate pathway of the complement system. J Immunol (1974) 1.44
Cloning and characterization of overlapping DNA fragments of the toxin A gene of clostridium difficile. J Gen Microbiol (1989) 1.44
Activation of human effector cells by different bacterial toxins (leukocidin, alveolysin, and erythrogenic toxin A): generation of interleukin-8. Infect Immun (1994) 1.44
Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes. J Immunol (1974) 1.44
The immune response to heterologous red cells in mice. 3. Cyclophosphamide-induced tolerance to multispecies rd cells. Pathol Microbiol (Basel) (1967) 1.42
Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system. J Immunol (1975) 1.39
[Heavy metal pollution of soil and garden products of Stolberg home gardens and lead and cadmium pollution of small farms in Stolberg]. Gesundheitswesen (1993) 1.39
Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol (1991) 1.38
Suppression of in vitro antibody synthesis by immunoglobulin-binding factor. J Exp Med (1975) 1.37
Soluble mediators of T-B interaction. Eur J Immunol (1973) 1.34
Effect of thiol-activated toxins (streptolysin O, alveolysin, and theta toxin) on the generation of leukotrienes and leukotriene-inducing and -metabolizing enzymes from human polymorphonuclear granulocytes. Infect Immun (1985) 1.34
Comparative study using various methods for identification of Staphylococcus species in clinical specimens. J Clin Microbiol (2006) 1.33
Leukotriene B4 generation and DNA fragmentation induced by leukocidin from Staphylococcus aureus: protective role of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF for human neutrophils. Infect Immun (1994) 1.32
Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies. J Immunol (1982) 1.32
Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry (2007) 1.32
Platelet activating factor (PAF) induces the oxidative burst in macrophages. Int J Immunopharmacol (1983) 1.31
A new, simple, bioassay for human IFN-gamma. J Immunol Methods (1994) 1.31
Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma. J Exp Med (1995) 1.30
Some aspects of IL-8 pathophysiology. III: Chemokine interaction with endothelial cells. J Leukoc Biol (1996) 1.30
Genus-specific epitope on the 60-kilodalton Legionella heat shock protein recognized by a monoclonal antibody. J Clin Microbiol (1991) 1.30
Generation of leukotrienes from human granulocytes by alveolysin from Bacillus alvei. Infect Immun (1984) 1.30
Arachidonic acid metabolites from polymorphonuclear leukocytes of healthy donors, severely burned patients and children with cystic fibrosis--routine monitoring by high-performance liquid chromatography. J Chromatogr (1988) 1.30
The neural basis of video gaming. Transl Psychiatry (2011) 1.28
Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci U S A (1988) 1.28
Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol (1976) 1.27